NCT02510859
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
- Locations
-
- Service ORL et de chirurgie cervico- faciale Caen CHU, France
Clinical trial condition
Carcinoma, Squamous Cell
Explore clinical trials studying Carcinoma, Squamous Cell. Study availability and eligibility vary by location and protocol.
1,631 public trials
442 recruiting studies
Carcinoma, Squamous Cell trial results
NCT04785820
- Conditions
- Advanced or Metastatic Esophageal Squamous Cell Carcinoma, Carcinoma, Carcinoma, Squamous Cell, +13 more
- Locations
-
- Inst. Alexander Fleming Buenos Aires, Argentina
- Centro Oncologico Riojano Integral (CORI) La Rioja, Argentina
- Hospital das Clinicas - UFRGS Porto Alegre, Rio Grande do Sul, Brazil
- Instituto do Cancer do Estado de Sao Paulo - ICESP São Paulo, Brazil
Completed
Safety Study of Afatinib and Postoperative Radiation Therapy to Treat Head and Neck Cancer
NCT01783587
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Mount Sinai Medical Center/Icahn School of Medicine at Mount Sinai New York, United States
Completed
Using MASL to Combat Oral Cancer
NCT04188665
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +5 more
- Locations
-
- New Jersey Medical School Newark, New Jersey, United States
- Rutgers School for Dental Medicine Newark, New Jersey, United States
- University Hospital Newark, New Jersey, United States
- Rowan University Stratford, New Jersey, United States
NCT06894771
- Conditions
- Adenocarcinoma, Breast Diseases, Breast Neoplasms, +45 more
- Locations
-
- John Theurer Cancer Center at Hackensack University Medical Center ( Site 0301) Hackensack, New Jersey, United States
- NEXT Oncology ( Site 0300) San Antonio, Texas, United States
- Princess Margaret Cancer Center ( Site 0101) Toronto, Ontario, Canada
- Centre intégré de cancérologie du CHU de Québec Université Laval, Hôpital de l'Enfant-Jésus ( Site 0102) Québec, Quebec, Canada
NCT04042935
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, HNSCC, +6 more
- Locations
-
- University of Colorado Hospital Aurora, Colorado, United States
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
- Locations
-
- Anhui Cancer Hospital-Radiology Department ( Site 3333) Hefei, Anhui, China
- Beijing Tongren Hospital affiliated to Capital Medical University ( Site 3343) Beijing, Beijing Municipality, China
- Beijing Cancer Hospital ( Site 3314) Beining, Beijing Municipality, China
- Peking Union Medical College Hospital ( Site 3304) Bejiing, Beijing Municipality, China
NCT04696744
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Circulating Tumor Cell, +18 more
- Locations
-
- Service ORL Chirurgie Cervico-faciale (Pr Philippe CERUSE) Lyon, France
NCT03313804
- Conditions
- Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +15 more
- Locations
-
- University of Kentucky Markey Cancer Center Lexington, Kentucky, United States
Completed
Phase II Randomized Trial of the Combination of Cetuximab and Sorafenib or Single Agent Cetuximab
NCT00939627
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +49 more
- Locations
-
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
- Emory University/Winship Cancer Institute Atlanta, Georgia, United States
- Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
- Suburban Hospital Bethesda, Maryland, United States